SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-023040
Filing Date
2019-05-01
Accepted
2019-05-01 17:15:22
Documents
4
Effectiveness Date
2019-05-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv520393_defa14a.htm DEFA14A 14763
2 GRAPHIC image_001.jpg GRAPHIC 63059
3 GRAPHIC image_002.jpg GRAPHIC 84483
4 GRAPHIC image_003.jpg GRAPHIC 38023
  Complete submission text file 0001144204-19-023040.txt   272006
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36860 | Film No.: 19788674
SIC: 2836 Biological Products, (No Diagnostic Substances)